-
2019 Analysis of the Global Melanoma Treatment Market - ResearchAndMarkets.com
19 Mar 2020 11:17 GMT
… The primary cause of Melanoma is prolonged exposure to … Technologies, AstraZeneca, Biogen Idec, Medarex, Reliance Life Sciences, Sanofi, … Melanoma
5.7 Superficial Melanoma
5.8 Cutaneous Melanoma
6 Global Melanoma … Biogen Idec
12.13 Medarex
12.14 Reliance Life …
-
Global Melanoma Market Report 2018 - Anticipated to Reach a Market Value of $14 Billion by 2024
20 Apr 2018 15:38 GMT
… Stage IV Melanoma
4.6 Recurrent Melanoma
5. Malignant Melanoma Management … of Global Melanoma Therapeutics
6.1 Global- Melanoma Chemotherapy … Registered
13. Marketed Malignant Melanoma Drug Clinical Insight
14 … Lorus Therapeutics
14.9 Medarex
14.10 Merck
14 …
-
Global Malignant Melanoma Drug Market Report 2018: Dosage, Price & Clinical Pipeline Outlook 2024
20 Apr 2018 07:17 GMT
… report highlights: Global Malignant Melanoma Drug Market Overview
Dosage … Stage IV Melanoma
4.6 Recurrent Melanoma
5. Malignant Melanoma Management … of Global Melanoma Therapeutics
6.1 Global- Melanoma Chemotherapy … Lorus Therapeutics
14.9 Medarex
14.10 Merck
…
-
Global Malignant Melanoma Drug Market & Clinical Pipeline Insight 2016 - 201 Drugs with 63 in Preclinical Phase & 25 Marketed Drugs
29 Jun 2016 10:51 GMT
… pipelines, innovative malignant melanoma therapeutics are expected to … Introduction to Malignant Melanoma
2. Malignant Melanoma Drug Mechanism of …
5. Global Malignant Melanoma Drug Market Future Prospects … Aptose Bioscience)
8.13 Medarex
8.14 Merck
8. …
-
Agenus: Serial Underperformer's Deep I-O Pipeline Approaching Key Inflection Points
20 Aug 2020 09:01 GMT
… in NSCLC, MSS tumors, melanoma and RCC). As for AGEN2373 … in additional indications like NSCLC, melanoma, RCC, HCC and others. … approval (include PD-1 refractory melanoma single arm study, in … Bristol-Myers Squibb (NYSE:BMY), Medarex, Genmab (NASDAQ:GMAB) and …
-
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Credit Suisse Biotech Management & Board Call Series Conference (Transcript)
22 Jun 2020 18:55 GMT
… was at a company called Medarex, which pioneered some of … that was sort of like Medarex on steroids.
And basically recognising … everyone else in the non-melanoma skin cancer phase. The first … know, coming over from Medarex and then obviously everything that …
-
Regeneron Pharmaceuticals, Inc. (REGN) Regeneron Oncology Investor Event, ASCO 2020 Conference (Transcript)
02 Jun 2020 03:51 GMT
… become leaders in the non-melanoma dermato-oncology space, based on … -1 at a company called Medarex. And after its acquisition by … another difficult to treat non-melanoma skin cancer.
Before turning the …
-
Documentary to be shown in Duluth portrays harmonica-playing Texan's breakthrough in cancer research
25 Feb 2020 19:45 GMT
… a small research company called Medarex and then, after initial reluctance … treated a patient who had melanoma with one of the earlier … March 4. In addition to melanoma, immunotherapy so far has been …
-
Study fingers new player in cancer immunity
24 Oct 2019 00:52 GMT
… variety of cancers, including melanoma, non-small cell lung … of aggressive, treatment-resistant melanoma. Indeed, PTPN2 deletion in … with this form of melanoma and slowed down tumor … Genentech, Bristol-Myers Squibb/Medarex, Amplimmune/Astrazeneca, Merck …
About
© 1995-2021